Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cigna    CI

CIGNA (CI)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Cigna Corporation (NYSE:CI) Files An 8-K Other Events

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2018 | 11:06am CEST

Cigna Corporation (NYSE:CI) Files An 8-K Other EventsItem 8.01 Other Events.

·
·
·
·

the availability of financing;

·

effects on the businesses as a result of uncertainty surrounding the proposed merger; and

·

the industry may be subject to future risks that are described in SEC reports filed by Express Scripts and Cigna.

You should carefully consider these and other relevant factors, including those risk factors in this communication and other risks and uncertainties that affect the businesses of Express Scripts and Cigna described in their respective filings with the SEC, when reviewing any forward-looking statement. These factors are noted for investors as permitted under the Private Securities Litigation Reform Act of 1995. Investors should understand it is impossible to predict or identify all such factors or risks. As such, you should not consider either foregoing lists, or the risks identified in SEC filings, to be a complete discussion of all potential risks or uncertainties.

IMPORTANT INFORMATION ABOUT THE TRANSACTION AND WHERE TO FIND IT

This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. In connection with the proposed transaction, the newly formed company which will become the holding company following the transaction ("Holdco") intends to file with the SEC a registration statement on Form S-4 that will include a joint proxy statement of Cigna and Express Scripts that also constitutes a prospectus of Holdco. Cigna and Express Scripts also plan to file other relevant documents with the SEC regarding the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. You may obtain a free copy of the joint proxy statement/prospectus (if and when it becomes available) and other relevant documents filed by Holdco, Cigna and Express Scripts with the SEC at the SEC's website at www.sec.gov. Copies of documents filed with the SEC by Cigna will be available free of charge on Cigna's website at www.Cigna.com or by contacting Cigna's Investor Relations Department at (215) 761-4198. Copies of documents filed with the SEC by Express Scripts will be available free of charge on Express Scripts' website at www.express-scripts.com or by contacting Express Scripts' Investor Relations Department at (314) 810-3115.

PARTICIPANTS IN THE SOLICITATION

Cigna (and, in some instances, Holdco) and Express Scripts and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction under the rules of the SEC. Investors may obtain information regarding the names, affiliations and interests of directors and executive officers of Cigna (and, in some instances, Holdco) in Cigna's Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the SEC on February 28, 2018, and its definitive proxy statement for its 2018 Annual Meeting, which was filed with the SEC on March 16, 2018. Investors may obtain information regarding the names, affiliations and interests of Express Scripts' directors and executive officers in Express Scripts' Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the SEC on February 27, 2018, and its proxy statement for its 2018 Annual Meeting, which was filed with the SEC on March 29, 2018. You may obtain free copies of these documents at the SEC's website at www.sec.gov, at Cigna's website at www.Cigna.com or by contacting Cigna's Investor Relations Department at (215) 761-4198. Copies of documents filed with the SEC by Express Scripts will be available free of charge on Express Scripts' website at www.express-scripts.com or by contacting Express Scripts' Investor Relations Department at (314) 810-3115. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction if and when they become available. Investors should read the joint proxy statement/prospectus carefully and in its entirety when it becomes available before making any voting or investment decisions.

NO OFFER OR SOLICITATION

This communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

About Cigna Corporation (NYSE:CI)
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate. The Global Health Care segment aggregates the commercial and Government operating segments. The Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. The Company’s Global Supplemental Benefits segment offers supplemental health, life and accident insurance products primarily in Asia, Europe and the United States. Its products are offered through employers and other groups, such as Governmental and non-Governmental organizations, unions and associations. Cigna also offers commercial health and dental insurance, and Medicare and Medicaid products and health.

The post Cigna Corporation (NYSE:CI) Files An 8-K Other Events appeared first on Market Exclusive.

© Market Exclusive 2018, source Market Exclusive

Stocks mentioned in the article
ChangeLast1st jan.
EXPRESS SCRIPTS HOLDING CO 2.31% 75.19 Delayed Quote.0.74%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA
11:06aCIGNA CORPORATION (NYSE : CI) Files An 8-K Other Events
AQ
04/23CIGNA CORP : Other Events (form 8-K)
AQ
04/17UnitedHealth earnings ease investor worries over flu season, stock up
RE
04/12CIGNA CORP : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
04/05CIGNA : Partnership with Physicians Successfully Reduces Opioid Use by 25 Percen..
AQ
04/05CIGNA CORPORATION : ’s First Quarter 2018 Earnings Release Details
BU
04/05CIGNA : America’s Favorite TV Doctors of America Are Now On-Call
BU
04/04GLANCY PRONGAY & MURRAY LLP : Announces Investigation on Behalf of Cigna Corpora..
BU
04/02CIGNA : Metropolitan Life Insurance Co. NY Cuts Position in CIGNA Co. (CI)
AQ
03/31COME FOR YOUR DRUGS, LEAVE WITH MORE : Walmart's new growth strategy?
RE
More news
News from SeekingAlpha
04/17Fixing Drug Costs 
04/16Health insurers/managed care firms up ahead of UNH Q1 earnings tomorrow 
04/12EXPRESS SCRIPTS : Heads (Cigna Buyout) Or Tails (Go Solo), Investors Can Win Eit.. 
04/08HEALTHCARE : Eating You Alive 
04/06Blue Cross Blue Shield Insurers may be afoul of antitrust law 
Financials ($)
Sales 2018 44 372 M
EBIT 2018 4 054 M
Net income 2018 2 923 M
Debt 2018 3 400 M
Yield 2018 0,03%
P/E ratio 2018 14,26
P/E ratio 2019 12,50
EV / Sales 2018 1,01x
EV / Sales 2019 0,79x
Capitalization 41 269 M
Chart CIGNA
Duration : Period :
Cigna Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 216 $
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA-16.32%41 269
UNITEDHEALTH GROUP6.62%227 459
AETNA-1.92%57 877
ANTHEM INC0.47%57 840
HUMANA18.56%40 496
CENTENE CORPORATION9.66%19 362